These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Riepe FG; Krone N; Krüger SN; Sweep FC; Lenders JW; Dötsch J; Mönig H; Sippell WG; Partsch CJ Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):105-10. PubMed ID: 16636975 [TBL] [Abstract][Full Text] [Related]
51. Lost lessons of glucocorticoid potency and the treatment of children with congenital adrenal hyperplasia. Rivkees SA J Pediatr Endocrinol Metab; 2008 Apr; 21(4):297-9. PubMed ID: 18556959 [No Abstract] [Full Text] [Related]
52. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. Cruse LM; Valeriano J; Vasey FB; Carter JD J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807 [TBL] [Abstract][Full Text] [Related]
53. Congenital adrenal hyperplasia: problems with developmental anomalies of the external genitalia and sex assignment. Al-Maghribi H Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):405-13. PubMed ID: 17679754 [TBL] [Abstract][Full Text] [Related]
56. [Tyrosine content in the blood as an index of the adequacy of glucocorticoid replacement therapy in congenital adrenal cortical dysfunction in children]. Rass IT; Kuznetsova ES; Zhukovskiĭ MA Pediatriia; 1979 Sep; (9):26-9. PubMed ID: 492854 [No Abstract] [Full Text] [Related]